Activation of the ATP-sensitive and calcium activated K+-channels by small synthetic molecules is a well-established pharmacodynamic concept for the treatment of hypertension and cardiac disorders, baldness and hyperglycemia.The sarcolemma ATP-sensitive K+ (sarco-KATP) and the big calcium-activated K+ (sarco-BK) channel subunits show muscle-phenotype-dependent functional and pharmacological properties that are associated with different molecular composition of the sarco-KATP and sarco-BK channels in the fast-twitch and slow-twitch fibers.The diversity of the sarco-KATP channels are due to a hybrid assembly of the sulphonylureas receptor SUR2A, SUR1 and SUR2B subunits and the inwardly rectifying potassium channel Kir6.2 in the muscle phenotypes.In the case of the sarco-BK channel, we established that the main mechanism regulating BK channel diversity is the alternative splicing of the KCNMA1/slo1 gene encoding for the alpha subunit generating different splicing isoform in the muscle phenotypes.This finding helps to design molecules selectively targeting the skeletal muscle subtypes.The use of drugs selectively targeting the skeletal muscle KATP and BK channels is a promising strategy in the treatment of familial disorders affecting muscular skeletal apparatus including hyperkalemic and hypokalemic periodic paralysis.

Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use

TRICARICO, Domenico;MELE, ANTONIETTA
2016-01-01

Abstract

Activation of the ATP-sensitive and calcium activated K+-channels by small synthetic molecules is a well-established pharmacodynamic concept for the treatment of hypertension and cardiac disorders, baldness and hyperglycemia.The sarcolemma ATP-sensitive K+ (sarco-KATP) and the big calcium-activated K+ (sarco-BK) channel subunits show muscle-phenotype-dependent functional and pharmacological properties that are associated with different molecular composition of the sarco-KATP and sarco-BK channels in the fast-twitch and slow-twitch fibers.The diversity of the sarco-KATP channels are due to a hybrid assembly of the sulphonylureas receptor SUR2A, SUR1 and SUR2B subunits and the inwardly rectifying potassium channel Kir6.2 in the muscle phenotypes.In the case of the sarco-BK channel, we established that the main mechanism regulating BK channel diversity is the alternative splicing of the KCNMA1/slo1 gene encoding for the alpha subunit generating different splicing isoform in the muscle phenotypes.This finding helps to design molecules selectively targeting the skeletal muscle subtypes.The use of drugs selectively targeting the skeletal muscle KATP and BK channels is a promising strategy in the treatment of familial disorders affecting muscular skeletal apparatus including hyperkalemic and hypokalemic periodic paralysis.
File in questo prodotto:
File Dimensione Formato  
CTP Rev_Vol 20_67-80.pdf

non disponibili

Descrizione: Articolo principale
Tipologia: Documento in Versione Editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 171.36 kB
Formato Adobe PDF
171.36 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/191847
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact